ASC42
Showing 1 - 25 of 78
Healthy Trial in Changsha (ASC42, Placebo)
Completed
- Healthy
- ASC42
- Placebo
-
Changsha, Hunan, ChinaXiangya Boai Rehabilitation Hospital
Jun 28, 2022
Primary Biliary Cholangitis Trial (ASC42 5 mg, ASC42 10 mg, ASC42 15 mg)
Not yet recruiting
- Primary Biliary Cholangitis
- ASC42 5 mg
- +3 more
- (no location specified)
Mar 9, 2022
Hepatitis B, Chronic Trial in Guangzhou (ASC42 10mg, ASC42 15mg, ih PEG-IFN a-2a)
Recruiting
- Hepatitis B, Chronic
- ASC42 10mg
- +4 more
-
Guangzhou, Guangdong, ChinaNanFang Hospital of Southern Medical University
Jan 13, 2022
Healthy Trial in San Antonio (ASC42, Placebo)
Completed
- Healthy
- ASC42
- Placebo
-
San Antonio, TexasICON early Phase Services LLC
Jun 25, 2021
Peripheral Arterial Disease Trial in Hoffman Estates
Recruiting
- Peripheral Arterial Disease
-
Hoffman Estates, IllinoisOutpatient Endovascular Interventional Society (OEIS)
Sep 27, 2022
Short Bowel Syndrome, Infection, Bacterial Trial (amoxicillin, levofloxacin, ofloxacin, sulfamethoxazole/trimethoprim)
Not yet recruiting
- Short Bowel Syndrome
- Infection, Bacterial
- amoxicillin, levofloxacin, ofloxacin, sulfamethoxazole/trimethoprim
- (no location specified)
Mar 21, 2022
Non-cystic Fibrosis Bronchiectasis Trial in United States (ARINA-1, Placebo)
Not yet recruiting
- Non-cystic Fibrosis Bronchiectasis
- ARINA-1
- Placebo
-
Birmingham, Alabama
- +8 more
Aug 10, 2022
HPV Testing for Cervical Cancer Screening in Women Living With
Recruiting
- HIV Seropositivity
-
Saint-Denis, FranceCentre Hospitalier de Saint-Denis
Jul 20, 2023
Elective Colonoscopy Trial in Worldwide (Phase II: NTC015 low dose, Phase II: NTC015 medium dose, Phase II: NTC015 high dose)
Completed
- Elective Colonoscopy
- Phase II: NTC015 low dose
- +4 more
-
Avignon, France
- +34 more
Jul 11, 2022
MDD Trial in Eatontown (CYB003, Psychotherapy, Placebo)
Recruiting
- Major Depressive Disorder
- CYB003
- +2 more
-
Eatontown, New JerseyClinilabs Drug Development Corporation
Jul 11, 2022
Gastroenteritis Escherichia Coli, Immunisation Trial in Dhaka (Placebo, Recombinant Double Mutant Heat-Labile Toxin
Terminated
- Gastroenteritis Escherichia Coli
- Immunisation
- Placebo
- Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral enterotoxigenic Escherichia coli (ETEC) Vaccine
-
Dhaka, BangladeshInternational Center for Diarrheal Disease Research Bangladesh -
Dec 16, 2021
Esophageal Cancer, Esophageal Tumors, Gastric Cancer Trial in Lund (evidence-based individualized rehabilitation)
Not yet recruiting
- Esophageal Cancer
- +3 more
- evidence-based individualized rehabilitation
-
Lund, SwedenSkåne University Hospital
Jan 16, 2023
Treatment Resistant Disorders, Post Traumatic Stress Disorder Trial in Windsor (Psilocybin)
Not yet recruiting
- Treatment Resistant Disorders
- Post Traumatic Stress Disorder
-
Windsor, Nova Scotia, CanadaHalucenex Life Sciences Inc.
Jul 27, 2022
Intrabony Periodontal Defect Trial in Mansoura (Freeze-dried bone allograft combined with Enamel Matrix derivative, Freeze-dried
Recruiting
- Intrabony Periodontal Defect
- Freeze-dried bone allograft combined with Enamel Matrix derivative
- Freeze-dried bone allograft
-
Mansoura, EgyptMansoura University
Sep 16, 2023
Advanced Cancer, Metastatic Cervical Cancer Trial in Albuquerque, Yerevan (Balstilimab (BAL), Topotecan, Vinorelbine)
Withdrawn
- Advanced Cancer
- Metastatic Cervical Cancer
- Balstilimab (BAL)
- +5 more
-
Albuquerque, New Mexico
- +2 more
Oct 3, 2022
Motor Planning and Movement Execution of Autism Spectrum
Recruiting
- Autism
- Autism Spectrum Disorder
- Kinematics measures
-
Messina, ItalyInstitute for Biomedical Research and Innovation (IRIB) - Nation
Nov 17, 2023
Treatment Resistant Depression Trial in Klecany (Psilocybin, Ketamine Hydrochloride, Midazolam Ph. Eur 9.0)
Recruiting
- Treatment Resistant Depression
- Psilocybin
- +2 more
-
Klecany, CzechiaNational Institute of Mental Health
May 16, 2022
Neurodevelopmental Disorders, Emotional Disorder, Behavior Disorders Trial in Taipei City (The RENEW Intervention)
Active, not recruiting
- Neurodevelopmental Disorders
- +2 more
- The RENEW Intervention
-
Taipei City, Shilin, TaiwanTaipei Adventist American School
Mar 23, 2022
Shigellosis, Bacillary Dysentery Trial in Silver Spring (Shigella flexneri 2a InvaplexAR)
Completed
- Shigellosis
- Bacillary Dysentery
- Shigella flexneri 2a InvaplexAR
-
Silver Spring, MarylandWalter Reed Army Institute of Research, Clinical Trials Center
Feb 10, 2021
Upper Extremity Exercise Capacity, Muscle Oxygenation, Balance
Completed
- Primary Ciliary Dyskinesia
-
Ankara, Turkey
- +1 more
May 17, 2022
Pain, Pain, Acute, Anesthesia Trial in Minneapolis (Sublingual Sufentanil, IV Fentanyl)
Completed
- Pain
- +2 more
- Sublingual Sufentanil
- IV Fentanyl
-
Minneapolis, MinnesotaUniversity of Minnesota
Apr 15, 2021